Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kymera Therapeutics Inc (NQ: KYMR ) 43.41 -1.59 (-3.53%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Kymera Therapeutics Inc < Previous 1 2 3 4 Next > The Analyst Landscape: 7 Takes On Kymera Therapeutics September 27, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics September 09, 2024 Via Benzinga This BJ's Wholesale Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday August 26, 2024 Via Benzinga Unveiling 6 Analyst Insights On Kymera Therapeutics August 12, 2024 Via Benzinga XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details July 14, 2024 10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit... Via Benzinga Why Kymera Therapeutics Stock Is Soaring Today July 09, 2024 Kymera's lead pipeline candidate received some good news. Via The Motley Fool Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics June 17, 2024 Via Benzinga Demystifying Kymera Therapeutics: Insights From 5 Analyst Reviews May 24, 2024 Via Benzinga Kymera Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) April 22, 2024 Via Benzinga Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 09, 2024 Via Benzinga Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday July 09, 2024 Via Benzinga KYMR Stock Earnings: Kymera Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 02, 2024 KYMR stock results show that Kymera Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views February 23, 2024 Via Benzinga Deep Dive Into Kymera Therapeutics Stock: Analyst Perspectives (4 Ratings) December 19, 2023 Via Benzinga Analyst Expectations for Kymera Therapeutics's Future November 13, 2023 Via Benzinga Piper Sandler Maintains Overweight Rating for Kymera Therapeutics: Here's What You Need To Know February 27, 2024 Via Benzinga Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering January 05, 2024 Shares soared and then tumbled Friday after the company offered $275 million in public shares. Via Investor's Business Daily More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying November 07, 2023 Although U.S. stocks closed slightly higher on Monday, there were a few notable insider trades. Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Kymera Therapeutics: Here's What You Need To Know November 03, 2023 Via Benzinga Why Shares of Kymera Therapeutics Jumped on Tuesday October 03, 2023 The company had a big bounce after hitting a 52-week low the day before. Via The Motley Fool Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday August 29, 2023 Stifel raised the price target for Hersha Hospitality Trust (NYSE: HT) from $8.75 to $10. Stifel analyst Simon Yarmak downgraded the stock from Buy to Hold. Hersha Hospitality Trust shares fell 0.5% to... Via Benzinga Expert Ratings for Kymera Therapeutics August 04, 2023 Via Benzinga What 5 Analyst Ratings Have To Say About Kymera Therapeutics June 15, 2023 Via Benzinga Earnings Scheduled For February 22, 2024 February 22, 2024 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. Via Benzinga Preview: Kymera Therapeutics's Earnings November 01, 2023 Via Benzinga The Latest Analyst Ratings for Kymera Therapeutics August 29, 2023 Via Benzinga Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session October 06, 2023 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 June 30, 2023 Via Benzinga Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 02, 2023 Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 02, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.